tinefcon is a result of 10 years of dedicated research. tinefcon is derived from an innovative, standardized extract of Sphaeranthus indicus for the successful management of psoriasis. Sphaeranthus indicus is a well-known phytopharmaceutical that is used for various chronic skin disorders as an immunomodulator and anti-inflammatory agent and helps maintain, restore, and enhance skin health. tinefcon is the first oral TNF-α inhibitor, is a natural and patented product for the successful management of psoriasis.

Advantages of tinefcon

Unlike other biological remedies, tinefcon doesn’t eliminate TNF-α (an immune system cell); it simply reduces its levels to a normal. tinefcon’s effects are less of a shock to the system and leave the remaining TNF-α cells available to perform their normal functions in the body.

tinefcon is a patented and clinically proven product with high-grade efficacy and safety for psoriasis patients. Available as oral tablets, creams, shampoos, and shower gels.
A 360-degree solution for the management of psoriasis.

tinefcon Benefits

Clinically proven and documented.
Unlike other biologics, it is orally active, safe, and non-toxic.
  • Reduces itchiness, pain, and redness.
  • Improved Psoriasis Area and Severity Index (PASI).
  • Down regulates psoriatic markers.
  • Regulator of the immune response.
  • Reduces epidermal thickness and enhances epidermal thinning.

Significant Clinical Evidence of tinefcon

Photographic evidence shown skin restoration during clinical trials conducted with tinefcon in 12 weeks of treatment.
  • A clear improvement was seen in photographic evidence after 12 weeks.
  • Shown efficacy in gold standard psoriasis assessment parameters like PASI (Psoriasis Area Severity Index).
  • Significant reduction in epidermal thickness of 66%.
  • Favorable Safety Profile
  • Good efficacy comparable to current biologics
  • No mortality or ECG abnormalities were reported.